HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY
Technology
E-065-2017
Patent ID
E-065-2017-0-PCT-02
Country
PCT
Application Type
PCT
Patent Status
Expired
Patent Number
Publication Number
WO 2018/213064
Application Number
PCT/US2018/031618
IC
NCI
Date Filed
Date Issued
Patent PDF